“…The Michael reaction has been recently applied to produce many biologically or pharmacologically active compounds, such as: prostaglandins [64], enzyme inhibitors (3C protease inhibitor [65], cathepsin K cysteine protease inhibitor [66]), potential anti-HIV drugs -(+) Inophyllum B and (+) Calanolide (A) [67], anticancer, antitubercular and antimicrobial agents (cyanopyranes an cyanopyridines [68]), vasopressin receptor V1A and V2 antagonists (spirobenzazepines [69]), peptides [70], antibiotics (semisynthetic macrolides based on Clarithromycin [71]), alkaloids (antimalarial alkaloid (+)-febrifugine [72]), antiepileptic drugs (vigabatrin, GABA aminotransferase inhibitor [73]) and odorants (octahydronaphtalene-based fragrances [74] and trans-magnolione [75]). …”